Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_assertion type Assertion NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_head.
- NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_assertion wasGeneratedBy ECO_0000203 NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_provenance.
- NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_assertion wasDerivedFrom lhgdn-20090331 NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_provenance.
- NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_assertion SIO_000772 19139306 NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_provenance.
- NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_assertion evidence source_evidence_literature NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_provenance.
- NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_provenance.